X-linked Chondrodysplasia Punctata 1

🏷

Classifications

Harrison's Part

ISDS Skeletal Nosology

🔗

Mappings

MONDO

MONDO:0010555 X-linked chondrodysplasia punctata 1

The dismech entry and the MONDO class denote the same entity: ARSL/ARSE-related X-linked recessive chondrodysplasia punctata. The acquired phenocopies that share its radiographic picture are deliberately excluded from both, and are handled here as differential diagnoses.

👪

Inheritance

1

X-linked recessive inheritance HP:0001419

Affected individuals are hemizygous males. Female carriers have not so far been reported as affected - the contrast with CDPX2, where the heterozygous female is the typical patient, follows from CDPX1 being recessive rather than dominant at the X-linked locus.

X-linked recessive inheritance

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and thus far have not been affected."

States the X-linked recessive pattern and the carrier status of females.

?

Discussions and Knowledge Gaps

2

What is the physiological substrate of ARSL, and what sulfated species links its loss to abnormal cartilage mineralization?

KNOWLEDGE GAP OPEN arsl_substrate_unknown

Attached to

pathophysiology#Unidentified Sulfated Substrate Accumulates or Fails to Be Processed pathophysiology#ARSL Arylsulfatase Deficiency

The gene has been known since 1995 and the enzyme deficiency has been demonstrated directly in patients, yet neither the substrate nor the function of the enzyme has been identified. Every consequence follows from that: there is no biochemical diagnostic test, no metabolite to monitor, no target for therapy, and a pathophysiology node in this entry that can only be named negatively. The gap is unusual among the chondrodysplasia punctata group, where the peroxisomal and sterol-pathway members all have solved biochemistry and quantitative diagnostic assays. Two clues constrain the answer - the enzyme's warfarin sensitivity, and the fact that early-gestation vitamin K deficiency phenocopies the disorder - which together point towards a vitamin-K-dependent process, but no candidate substrate has been confirmed.

Proposed experiments

Substrate identification for ARSL

arsl_substrate_identification

Untargeted sulfatomic profiling of ARSL-deficient versus control chondrocytes or cartilage, with the warfarin-inhibited enzyme as a pharmacological comparator, to identify sulfated species that accumulate on loss of activity; candidates then tested as direct substrates of recombinant enzyme.

Show evidence (1 reference)

PMID:18348268 SUPPORT Human Clinical

"Neither the substrate nor function of the encoded warfarin-sensitive arylsulfatase has been identified and molecular analysis remains the only confirmatory diagnostic test."

States the gap and its immediate diagnostic consequence.

Is "brachytelephalangic chondrodysplasia punctata" a disease, or a radiographic convergence point reached by an inherited sulfatase deficiency and by several unrelated maternal-fetal insults?

KNOWLEDGE GAP OPEN bcdp_entity_status

Attached to

disease#X-linked Chondrodysplasia Punctata 1 differential_diagnoses#Vitamin K deficiency and maternal autoimmune phenocopies of brachytelephalangic CDP

This is a nosological question with practical teeth. The ISDS nosology lists the ARSL-related entity as a single row, and this dismech entry follows it - but the clinical literature reports that most patients meeting the clinical criteria have no ARSL variant, that examination cannot separate the genetic from the acquired cases, and in one report that the pattern "is most probably not a diagnostic entity". If that view is right, the useful dismech object might eventually be a grouping over the convergent causes rather than a disease entry per cause. dismech keeps the gene-defined entry because that is what the nosology lists and what MONDO:0010555 denotes, and records the acquired routes as differentials rather than as subtypes, but the boundary is not settled.

Show evidence (2 references)

PMID:32506814 SUPPORT Human Clinical

"This case shows that BCDP is most probably not a diagnostic entity and can be associated with various conditions associated with CDP including maternal SLE."

States the position that the radiographic pattern is not a disease entity.

PMID:18348268 SUPPORT Human Clinical

"This study supports heterogeneity for CDPX1-like phenotypes and sorting these out will help to define the biological pathway and genetic contributors."

The authors of the largest systematic series frame the heterogeneity of the clinical category as unresolved.

⚙

Pathophysiology

5

ARSL Arylsulfatase Deficiency

Hemizygous loss-of-function variants in ARSL (formerly ARSE) abolish a heat-labile arylsulfatase activity localized to Xp22.3. The gene was found by positional cloning of the CDPX region, and the enzyme deficiency was demonstrated directly in patients carrying deletions spanning that region - so the enzymatic lesion is established even though what the enzyme normally does is not.

Genetic context ARSL hgnc:719 variant_origin: GERMLINE zygosity: HEMIZYGOUS functional_impact_category: LOSS_OF_FUNCTION

Hemizygous germline point mutations, and in about a quarter of molecularly solved cases Xp deletions or rearrangements. Heterozygous females are carriers and have not so far been reported as affected.

arylsulfatase activity GO:0004065 ⇓ LOSS OF FUNCTION

Downstream

Unidentified Sulfated Substrate Accumulates or Fails to Be Processed The immediate biochemical consequence of losing a sulfatase is that its substrate is not desulfated. In this case that substrate has never been identified, so the node is a placeholder for a real but uncharacterized step.

Show evidence (2 references)

PMID:7720070 SUPPORT Human Clinical

"Point mutations in one of these genes were identified in five patients with CDPX."

Establishes the gene assignment in patients.

PMID:7720070 SUPPORT Human Clinical

"A deficiency of a heat-labile arylsulfatase activity was demonstrated in patients with deletions spanning the CDPX region."

Demonstrates the enzyme deficiency itself in patients, not merely the genotype.

Unidentified Sulfated Substrate Accumulates or Fails to Be Processed

An explicitly unresolved node. ARSL's physiological substrate has not been identified, so the step between the enzyme deficiency and the cartilage phenotype is empty. It is modelled rather than omitted because the shape of the gap matters: the warfarin sensitivity of the enzyme and the vitamin-K-deficiency phenocopies both point towards a vitamin-K-dependent process, and that is the leading hypothesis for what should occupy this node.

Downstream

Abnormal Cartilage Calcification and Endochondral Ossification Whatever the missing step is, its endpoint is disordered mineralization of developing bone and cartilage - the feature by which the disorder was originally characterized.

Show evidence (1 reference)

PMID:18348268 SUPPORT Human Clinical

"This study supports heterogeneity for CDPX1-like phenotypes and sorting these out will help to define the biological pathway and genetic contributors."

The authors frame identification of the biological pathway as still outstanding.

Warfarin-Sensitive Enzyme Activity

Recombinant ARSL expressed in COS cells yields an arylsulfatase activity that is inhibited by warfarin. This is not a feature of the disease so much as the bridge between the genetic disorder and its most important phenocopy: a coumarin taken by the mother during a critical window can pharmacologically produce the same enzyme deficiency the mutation produces genetically. It is modelled as its own node because it is the mechanistic claim that unifies CDPX1 with warfarin embryopathy and, more speculatively, with the vitamin-K-deficiency phenocopies.

Downstream

ARSL Arylsulfatase Deficiency Pharmacological inhibition reaches the same molecular endpoint as the genetic lesion. The authors advance this as the mechanism of warfarin embryopathy, in which a fetus with an intact ARSL gene nonetheless has deficient enzyme activity.

Show evidence (1 reference)

PMID:7720070 SUPPORT In Vitro

"Expression of this gene in COS cells resulted in a heat-labile arylsulfatase activity that is inhibited by warfarin."

Demonstrates the warfarin sensitivity of the enzyme in a heterologous expression system.

Abnormal Cartilage Calcification and Endochondral Ossification

Punctate calcification appears in epiphyseal and other cartilage, with a distribution that in this disorder is weighted towards the nasal cartilage and the distal phalanges rather than towards the proximal long bones. That regional weighting is what separates the brachytelephalangic pattern from the rhizomelic one radiographically, and it is unexplained.

chondrocyte CL:0000138 growth plate cartilage chondrocyte CL:1000217

bone mineralization GO:0030282 ⚠ ABNORMAL endochondral ossification GO:0001958 ⚠ ABNORMAL

Downstream

Epiphyseal Stippling Punctate calcification of epiphyseal cartilage is the defining radiographic finding.

Nasomaxillary Hypoplasia Underdevelopment of the nasal cartilage and maxilla, the craniofacial expression of the same cartilage lesion.

Brachytelephalangy Shortening of the distal phalanges.

Cervical Spine Stenosis and Instability The cervical spine is the site where the dysplasia has its most dangerous consequence, and unlike the other skeletal findings it does not improve with age.

Show evidence (1 reference)

PMID:26526591 SUPPORT Human Clinical

"X-linked recessive type chondrodysplasia punctata (CDPX1) is a congenital disorder of cartilage and bone development with typical findings of stippled epyphises, nasomaxillary hypoplasia and short distal phalanges in a male patient."

States the cartilage-and-bone-development lesion and its three typical findings.

Nasomaxillary Hypoplasia

Severe underdevelopment of the nasal cartilage with maxillary hypoplasia, producing the flat midface and depressed nasal bridge that are the clinical signature of the brachytelephalangic pattern. In the newborn it is also a mechanical airway problem.

Downstream

Hypoplasia of the Maxilla The maxillary component of the midface hypoplasia.

Depressed Nasal Bridge The flat nasal bridge is the surface expression of the underdeveloped nasal cartilage named in this node.

Respiratory Distress Nasal-airway compromise in infancy, the reason nasal stents and supplemental oxygen appear in the management recommendations.

Show evidence (1 reference)

PMID:7720070 SUPPORT Human Clinical

"X-linked recessive chondrodysplasia punctata (CDPX) is a congenital defect of bone and cartilage development characterized by aberrant bone mineralization, severe underdevelopment of nasal cartilage, and distal phalangeal hypoplasia."

Names severe underdevelopment of nasal cartilage as a defining feature.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

8

Head and Neck 1

Depressed Nasal Bridge HP:0005280

Show evidence (1 reference)

PMID:7720070 SUPPORT Human Clinical

"severe underdevelopment of nasal cartilage"

Underdevelopment of the nasal cartilage is the anatomic basis of the depressed nasal bridge.

Musculoskeletal 1

Cervical Spine Stenosis and Instability Cervical spine instability HP:0010646

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Assess for cervical spine instability by flexion-extension radiographs every six to twelve months until growth is completed."

The recommended interval imaging establishes cervical instability as an expected and actively monitored complication.

Nervous System 1

Intellectual Disability HP:0001249

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Although most affected males have minimal morbidity and skeletal findings that improve by adulthood, some have significant medical problems including respiratory involvement, cervical spine stenosis and instability, mixed conductive and sensorineural hearing loss, and intellectual disability."

Support is recorded as partial because the source places intellectual disability explicitly in the minority "some have" group rather than among the characterizing features.

Respiratory 1

Respiratory Distress HP:0002098

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Treatment of respiratory difficulty as per ENT and/or pulmonologist including nasal stents and oxygen as needed."

Documents respiratory difficulty and its airway-directed management.

Other 4

Epiphyseal Stippling HP:0010655

Temporal: TRANSIENT

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"X-linked chondrodysplasia punctata 1 (CDPX1) is characterized by chondrodysplasia punctata (stippled epiphyses), brachytelephalangy (shortening of the distal phalanges), and nasomaxillary hypoplasia."

Names stippled epiphyses as one of the three characterizing findings.

Brachytelephalangy Shortening of all distal phalanges of the fingers HP:0006118

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"brachytelephalangy (shortening of the distal phalanges)"

Defines brachytelephalangy as distal phalangeal shortening.

Hypoplasia of the Maxilla HP:0000327

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Severe maxillary hypoplasia or maxillary retrognathia may require reconstructive surgery in older individuals."

Documents maxillary hypoplasia as a manifestation with surgical consequences.

Mixed Hearing Impairment HP:0000410

Show evidence (2 references)

PMID:20301713 SUPPORT Human Clinical

"mixed conductive and sensorineural hearing loss, and intellectual disability"

Names mixed conductive and sensorineural hearing loss among the significant problems.

PMID:26526591 SUPPORT Human Clinical

"We report on a male patient refered to clinical geneticist for congenital hearing loss and mild dysplastic signs, both phenotypic features being relatively unspecific and non suggestive of CDPX1 in first instance."

Documents a case in which hearing loss, not the skeletal dysplasia, was the presenting feature.

🧬

Genetic Associations

1

ARSL

Gene: ARSL hgnc:719 relationship_type: CAUSATIVE

Show evidence (2 references)

PMID:20301713 SUPPORT Human Clinical

"The diagnosis of CDPX1 is established in a male proband with typical clinical and radiographic findings and a hemizygous ARSL pathogenic variant identified by molecular genetic testing."

States the gene and the hemizygous requirement for diagnosis.

PMID:18348268 SUPPORT Human Clinical

"We identified mutations in seven individuals."

Seven of eleven patients meeting clinical criteria had identifiable variants in this systematic series.

💊

Medical Actions

4

Cervical spine surveillance, immobilization, and decompression

Action: surgical procedure Ontology label: Surgical Procedure NCIT:C15329

Flexion-extension radiographs every six to twelve months until growth is complete; a cervical collar or spinal fusion for instability; decompression for stenosis. Neck extension, neck flexion, and contact sports are to be avoided in an affected individual with instability, and the cervical spine should be imaged before general anaesthesia.

Target Phenotypes: cervical spine instability HP:0010646

Show evidence (2 references)

PMID:20301713 SUPPORT Human Clinical

"Instability of the cervical spine may require a cervical collar or spinal fusion. Decompression for cervical spine stenosis as needed."

States the interventions for cervical instability and stenosis.

PMID:20301713 SUPPORT Human Clinical

"In case of general anesthesia, the cervical spine should be assessed by imaging prior to the procedure."

Documents the pre-anaesthetic imaging requirement, an actionable safety consequence of the diagnosis.

Airway management in infancy

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Nasal stents and supplemental oxygen for respiratory difficulty from nasal hypoplasia.

Target Phenotypes: respiratory distress HP:0002098

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Treatment of respiratory difficulty as per ENT and/or pulmonologist including nasal stents and oxygen as needed."

States the airway interventions.

Hearing aids and pressure equalization tubes

Action: therapeutic procedure Ontology label: Therapeutic Procedure NCIT:C49236

Standard management of the mixed conductive and sensorineural hearing loss.

Target Phenotypes: mixed hearing impairment HP:0000410

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Hearing aids and pressure equalization tubes may be needed for hearing loss."

States the hearing-loss interventions.

Maxillofacial reconstruction

Action: orthopedic surgical procedure Ontology label: Orthopedic Surgical Procedure NCIT:C16186

Reconstructive surgery for severe maxillary hypoplasia or retrognathia in older individuals.

Target Phenotypes: hypoplasia of the maxilla HP:0000327

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Severe maxillary hypoplasia or maxillary retrognathia may require reconstructive surgery in older individuals."

States the reconstructive indication.

🔬

Diagnosis

2

Molecular testing of ARSL

Diagnosis requires typical clinical and radiographic findings plus a hemizygous ARSL variant. There is no biochemical confirmatory test: enzyme assay is not clinically available, and because the substrate is unknown there is no metabolite to measure. That is a real diagnostic handicap in a disorder whose most important differentials are acquired.

molecular genetic testing NCIT:C15709

Show evidence (2 references)

PMID:20301713 SUPPORT Human Clinical

"Testing of ARSL enzymatic activity is not currently available on a clinical basis."

States that no clinical enzyme assay exists.

PMID:18348268 SUPPORT Human Clinical

"molecular analysis remains the only confirmatory diagnostic test"

Confirms that molecular testing is the sole confirmatory route.

Maternal history as part of the diagnostic workup

Because the phenocopies are indistinguishable on examination, evaluating a stippled male infant means taking a maternal history - coumarin exposure, vitamin K status, autoimmune disease - as seriously as the molecular test. The largest systematic series found maternal conditions in three of the four patients who had no ARSL variant.

diagnostic procedure NCIT:C18020

Show evidence (2 references)

PMID:18348268 SUPPORT Human Clinical

"Of the remainder, three had maternal conditions that further expand the phenocopy group."

Documents that maternal conditions accounted for most of the variant-negative patients in this series.

PMID:18348268 SUPPORT Human Clinical

"We extracted clinical information from all prior reports over the past decade and show that there are few distinguishing features on examination between these two groups of patients."

Establishes that examination alone cannot separate genetic CDPX1 from its phenocopies, which is why the maternal history carries diagnostic weight.

📈

Progression

3

Neonatal period - airway and radiographic presentation

The disorder presents in the newborn with stippled epiphyses and nasomaxillary hypoplasia, and the immediate clinical risk is airway rather than skeletal, since obligate nasal breathers with severe nasal hypoplasia may need stenting or oxygen.

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Treatment of respiratory difficulty as per ENT and/or pulmonologist including nasal stents and oxygen as needed."

Identifies airway management as the acute intervention, consistent with a nasal-hypoplasia mechanism.

Childhood - radiographic improvement with persisting cervical spine risk

The skeletal findings improve by adulthood in most affected males, which is why the diagnosis is often missed or made late. Cervical spine instability runs against that trend and is the reason for interval flexion-extension imaging until growth is complete.

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Although most affected males have minimal morbidity and skeletal findings that improve by adulthood, some have significant medical problems including respiratory involvement, cervical spine stenosis and instability, mixed conductive and sensorineural hearing loss, and intellectual disability."

States both the generally favourable trajectory and the specific serious complications that qualify it.

Later childhood and adulthood - reconstructive and functional needs

Severe maxillary hypoplasia or retrognathia may need reconstruction in older individuals, and hearing loss requires ongoing management. The skeletal dysplasia itself becomes radiographically quiet.

Show evidence (1 reference)

PMID:20301713 SUPPORT Human Clinical

"Severe maxillary hypoplasia or maxillary retrognathia may require reconstructive surgery in older individuals."

States the later reconstructive need.

📊

Prevalence

2

Genetically confirmed patients reported in the literature

Cases In Literature Ultra Rare

No population prevalence estimate is available. The published count of molecularly confirmed cases is the only quantitative handle, and it is small - the figure below is as of 2015.

Show evidence (1 reference)

PMID:26526591 SUPPORT Human Clinical

"Disease is caused due to the loss of arylsulfatase E activity and only 55 patients with genetically confirmed disease have been reported so far."

Gives the count of genetically confirmed cases, which is the closest available proxy for how rare the molecularly defined entity is.

Patients meeting clinical CDPX1 criteria, proportion with an identified variant

Unknown Unknown

Two figures that look contradictory but are not: among patients in whom a variant is found, sequencing detects most and deletion/rearrangement analysis the rest; but among patients merely meeting clinical criteria, a large fraction have no ARSL variant at all. Both numbers matter for testing strategy, and the second is the reason the phenocopy group exists.

Show evidence (2 references)

PMID:26526591 SUPPORT Human Clinical

"In 60-75 % of all patients the mutation in ARSE gene is detected by sequence analysis and in further 25 % of patients Xp deletions or rearrangements are causative and may be identified by classical chromosome studies."

Establishes that a normal sequencing result does not exclude the diagnosis, since a quarter of causative lesions are deletions or rearrangements.

PMID:18348268 SUPPORT Human Clinical

"Nevertheless, the majority of patients evaluated have not had identifiable mutations in ARSE, and thus far 23 patients have been reported."

Establishes that most clinically ascertained patients are variant-negative, which is the observation the phenocopy group explains.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from X-linked Chondrodysplasia Punctata 1:

Warfarin (coumarin) embryopathy

Overlapping Features The phenocopy that the gene-discovery work itself explained. A fetus exposed to a coumarin derivative in early gestation develops a virtually identical picture, proposed to be drug-induced inhibition of the same warfarin-sensitive arylsulfatase. It is a differential diagnosis rather than a form of CDPX1, since the ARSL gene is intact.

Distinguishing Features

A maternal history of coumarin exposure in the first trimester
No ARSL variant is identifiable
Female infants can be affected, whereas genetic CDPX1 affects hemizygous males

Show evidence (1 reference)

PMID:7720070 SUPPORT Human Clinical

"A virtually identical phenotype is observed in the warfarin embryopathy, which is due to the teratogenic effects of coumarin derivatives during pregnancy."

States that the phenotypes are virtually identical, which is why this is the primary differential rather than a distant one.

Vitamin K deficiency and maternal autoimmune phenocopies of brachytelephalangic CDP

Overlapping Features Early-gestation vitamin K deficiency and maternal autoimmune disease, notably systemic lupus erythematosus, produce the same brachytelephalangic picture. In the largest systematic series these accounted for most of the variant-negative patients, and the authors report few distinguishing features on examination. One report of a newborn with brachytelephalangic CDP, maternal SLE, and two unrelated de novo variants goes further and argues the radiographic pattern is not a diagnostic entity at all.

Distinguishing Features

A maternal history of autoimmune disease or of a condition causing vitamin K deficiency
No ARSL variant is identifiable
Affected infants of either sex

Show evidence (2 references)

PMID:18348268 SUPPORT Human Clinical

"The major clinical features in these patients are also present in a group now recognized as phenocopies, due to vitamin K deficiency in early gestation or maternal autoimmune disease."

Names the two acquired phenocopy mechanisms.

PMID:32506814 SUPPORT Human Clinical

"This case shows that BCDP is most probably not a diagnostic entity and can be associated with various conditions associated with CDP including maternal SLE."

The strongest published statement of the position that the brachytelephalangic pattern names a convergence rather than a disease.

X-linked chondrodysplasia punctata 2 (Conradi-Hunermann-Happle syndrome) MONDO:0020603

Overlapping Features The other X-linked CDP and the source of most naming confusion, since both are "X-linked chondrodysplasia punctata". They share almost nothing else: CDPX2 is dominant, sterol-pathway, male-lethal, and mosaic.

Distinguishing Features

CDPX2 affects heterozygous females and is lethal in hemizygous males; CDPX1 affects hemizygous males and spares carrier females
CDPX2 has ichthyosis, follicular atrophoderma, scarring alopecia, and cataract; CDPX1 has none of these
CDPX2 has asymmetric rhizomelic shortening; CDPX1 has brachytelephalangy and nasomaxillary hypoplasia
CDPX2 has a diagnostic sterol profile; CDPX1 has no biochemical marker at all

{ }

Source YAML

click to show

name: X-linked Chondrodysplasia Punctata 1
creation_date: "2026-08-27T00:00:00Z"
category: Mendelian
description: >-
  X-linked recessive chondrodysplasia punctata type 1 (CDPX1, brachytelephalangic
  chondrodysplasia punctata) is caused by hemizygous loss-of-function variants in ARSL
  (arylsulfatase L, formerly ARSE) at Xp22.33, and presents in males with the triad of
  stippled epiphyses, shortening of the distal phalanges, and nasomaxillary hypoplasia.
  It is the outlier of its skeletal nosology group in a specific and instructive way:
  every other member has a solved biochemistry, whereas here the causal gene has been
  known since 1995 while the enzyme's physiological substrate and function remain
  unidentified, so there is no metabolite assay and molecular testing is the only
  confirmatory test. What the enzyme is known to have is a pharmacological property -
  the recombinant arylsulfatase activity is inhibited by warfarin - and that single
  observation carries most of the disorder's explanatory weight, because it is the
  reason a maternal coumarin exposure produces a virtually identical embryopathy. That
  convergence has since widened: the same brachytelephalangic radiographic picture
  arises from early-gestation vitamin K deficiency and from maternal autoimmune disease,
  and in the largest systematic series most patients meeting clinical criteria for CDPX1
  had no identifiable ARSL variant while several instead had a maternal condition. The
  practical consequence is that the radiographic pattern names a convergence point
  rather than a diagnosis, and one author group argues on that basis that
  brachytelephalangic CDP is probably not a diagnostic entity at all. Clinically most
  affected males have minimal morbidity and skeletal findings that improve into
  adulthood, but a minority have serious problems - nasal-airway and respiratory
  compromise in infancy, and cervical spine stenosis and instability, which is the
  finding that makes this an entry with a real surveillance and anaesthetic-safety
  consequence.
synonyms:
- CDPX1
- Brachytelephalangic chondrodysplasia punctata
- X-linked recessive chondrodysplasia punctata
- Arylsulfatase E deficiency
- ARSL-related chondrodysplasia punctata
- Chondrodysplasia punctata 1, X-linked recessive
disease_term:
  preferred_term: X-linked chondrodysplasia punctata 1
  term:
    id: MONDO:0010555
    label: X-linked chondrodysplasia punctata 1
parents:
- X-linked Chondrodysplasia Punctata
- Skeletal Dysplasia
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    notes: >-
      An X-linked Mendelian skeletal dysplasia. This Part is a particularly good fit
      here because the entity's central problem is the boundary between an inherited
      cause and an environmental/maternal one - the group of phenocopies that share its
      radiographic picture.
    evidence:
    - reference: PMID:20301713
      reference_title: "Chondrodysplasia Punctata 1, X-Linked."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "CDPX1 is inherited in an X-linked manner."
      explanation: Confirms the Mendelian X-linked basis that places the entry in this Part.
  isds_skeletal_category:
  - classification_value: chondrodysplasia_punctata
    notes: >-
      ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (Unger et al.,
      PMID:36779427), group 23 "Chondrodysplasia punctata (CDP) group", row
      NOS 23-0010 "CDP, X-linked recessive, ARSE-related (brachytelephalangic type;
      CDPX1)" (MIM 302950). Carried forward from the 2019 revision (Mortier et al.,
      PMID:31633310), where the group was numbered 21. The nosology row names the gene
      ARSE, which is the previous HGNC symbol; the current symbol is ARSL and that is
      what this entry uses. Note that only the genetic entity is a nosology row - the
      warfarin-embryopathy, vitamin-K-deficiency, and maternal-autoimmune phenocopies
      share the radiographic pattern but are not inherited skeletal disorders and are
      correctly absent from the table.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0010555
      label: X-linked chondrodysplasia punctata 1
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      The dismech entry and the MONDO class denote the same entity: ARSL/ARSE-related
      X-linked recessive chondrodysplasia punctata. The acquired phenocopies that share
      its radiographic picture are deliberately excluded from both, and are handled here
      as differential diagnoses.
references:
- reference: PMID:20301713
  title: "Chondrodysplasia Punctata 1, X-Linked."
  tags:
  - GeneReviews
- reference: PMID:7720070
  title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
- reference: PMID:18348268
  title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
- reference: PMID:26526591
  title: "Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss."
- reference: PMID:32506814
  title: "Maternal SLE and brachytelephalangic chondrodysplasia punctata in a patient with unrelated de novo RAF1 and SIX2 variants."
prevalence:
- population: Genetically confirmed patients reported in the literature
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No population prevalence estimate is available. The published count of
    molecularly confirmed cases is the only quantitative handle, and it is small - the
    figure below is as of 2015.
  evidence:
  - reference: PMID:26526591
    reference_title: "Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Disease is caused due to the loss of arylsulfatase E activity and only 55 patients
      with genetically confirmed disease have been reported so far.
    explanation: >-
      Gives the count of genetically confirmed cases, which is the closest available
      proxy for how rare the molecularly defined entity is.
- population: Patients meeting clinical CDPX1 criteria, proportion with an identified variant
  measure_type: UNKNOWN
  prevalence_class: UNKNOWN
  notes: >-
    Two figures that look contradictory but are not: among patients in whom a variant is
    found, sequencing detects most and deletion/rearrangement analysis the rest; but
    among patients merely meeting clinical criteria, a large fraction have no ARSL
    variant at all. Both numbers matter for testing strategy, and the second is the
    reason the phenocopy group exists.
  evidence:
  - reference: PMID:26526591
    reference_title: "Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 60-75 % of all patients the mutation in ARSE gene is detected by sequence
      analysis and in further 25 % of patients Xp deletions or rearrangements are
      causative and may be identified by classical chromosome studies.
    explanation: >-
      Establishes that a normal sequencing result does not exclude the diagnosis, since a
      quarter of causative lesions are deletions or rearrangements.
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nevertheless, the majority of patients evaluated have not had identifiable
      mutations in ARSE, and thus far 23 patients have been reported.
    explanation: >-
      Establishes that most clinically ascertained patients are variant-negative, which
      is the observation the phenocopy group explains.
progression:
- phase: Neonatal period - airway and radiographic presentation
  notes: >-
    The disorder presents in the newborn with stippled epiphyses and nasomaxillary
    hypoplasia, and the immediate clinical risk is airway rather than skeletal, since
    obligate nasal breathers with severe nasal hypoplasia may need stenting or oxygen.
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment of respiratory difficulty as per ENT and/or pulmonologist including
      nasal stents and oxygen as needed.
    explanation: >-
      Identifies airway management as the acute intervention, consistent with a
      nasal-hypoplasia mechanism.
- phase: Childhood - radiographic improvement with persisting cervical spine risk
  notes: >-
    The skeletal findings improve by adulthood in most affected males, which is why the
    diagnosis is often missed or made late. Cervical spine instability runs against that
    trend and is the reason for interval flexion-extension imaging until growth is
    complete.
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although most affected males have minimal morbidity and skeletal findings that
      improve by adulthood, some have significant medical problems including respiratory
      involvement, cervical spine stenosis and instability, mixed conductive and
      sensorineural hearing loss, and intellectual disability.
    explanation: >-
      States both the generally favourable trajectory and the specific serious
      complications that qualify it.
- phase: Later childhood and adulthood - reconstructive and functional needs
  notes: >-
    Severe maxillary hypoplasia or retrognathia may need reconstruction in older
    individuals, and hearing loss requires ongoing management. The skeletal dysplasia
    itself becomes radiographically quiet.
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Severe maxillary hypoplasia or maxillary retrognathia may require reconstructive
      surgery in older individuals.
    explanation: States the later reconstructive need.
pathophysiology:
- name: ARSL Arylsulfatase Deficiency
  biological_scale: MOLECULAR
  description: >-
    Hemizygous loss-of-function variants in ARSL (formerly ARSE) abolish a
    heat-labile arylsulfatase activity localized to Xp22.3. The gene was found by
    positional cloning of the CDPX region, and the enzyme deficiency was demonstrated
    directly in patients carrying deletions spanning that region - so the enzymatic
    lesion is established even though what the enzyme normally does is not.
  genetic_context:
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HEMIZYGOUS
    gene:
      preferred_term: ARSL
      term:
        id: hgnc:719
        label: ARSL
    description: >-
      Hemizygous germline point mutations, and in about a quarter of molecularly solved
      cases Xp deletions or rearrangements. Heterozygous females are carriers and have
      not so far been reported as affected.
  molecular_functions:
  - preferred_term: arylsulfatase activity
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0004065
      label: arylsulfatase activity
  evidence:
  - reference: PMID:7720070
    reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Point mutations in one of these genes were identified in five patients with CDPX."
    explanation: Establishes the gene assignment in patients.
  - reference: PMID:7720070
    reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A deficiency of a heat-labile arylsulfatase activity was demonstrated in patients
      with deletions spanning the CDPX region.
    explanation: >-
      Demonstrates the enzyme deficiency itself in patients, not merely the genotype.
  downstream:
  - target: Unidentified Sulfated Substrate Accumulates or Fails to Be Processed
    description: >-
      The immediate biochemical consequence of losing a sulfatase is that its substrate
      is not desulfated. In this case that substrate has never been identified, so the
      node is a placeholder for a real but uncharacterized step.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:18348268
      reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Neither the substrate nor function of the encoded warfarin-sensitive arylsulfatase
        has been identified and molecular analysis remains the only confirmatory
        diagnostic test.
      explanation: >-
        States directly that the substrate is unknown, which is why this node cannot be
        specified further.
- name: Unidentified Sulfated Substrate Accumulates or Fails to Be Processed
  biological_scale: MOLECULAR
  description: >-
    An explicitly unresolved node. ARSL's physiological substrate has not been
    identified, so the step between the enzyme deficiency and the cartilage phenotype is
    empty. It is modelled rather than omitted because the shape of the gap matters: the
    warfarin sensitivity of the enzyme and the vitamin-K-deficiency phenocopies both
    point towards a vitamin-K-dependent process, and that is the leading hypothesis for
    what should occupy this node.
  evidence:
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This study supports heterogeneity for CDPX1-like phenotypes and sorting these out
      will help to define the biological pathway and genetic contributors.
    explanation: >-
      The authors frame identification of the biological pathway as still outstanding.
  downstream:
  - target: Abnormal Cartilage Calcification and Endochondral Ossification
    description: >-
      Whatever the missing step is, its endpoint is disordered mineralization of
      developing bone and cartilage - the feature by which the disorder was originally
      characterized.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:7720070
      reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        X-linked recessive chondrodysplasia punctata (CDPX) is a congenital defect of
        bone and cartilage development characterized by aberrant bone mineralization,
        severe underdevelopment of nasal cartilage, and distal phalangeal hypoplasia.
      explanation: >-
        Defines the phenotype as aberrant bone mineralization with the specific
        nasal-cartilage and distal-phalangeal pattern.
- name: Warfarin-Sensitive Enzyme Activity
  biological_scale: MOLECULAR
  description: >-
    Recombinant ARSL expressed in COS cells yields an arylsulfatase activity that is
    inhibited by warfarin. This is not a feature of the disease so much as the bridge
    between the genetic disorder and its most important phenocopy: a coumarin taken by
    the mother during a critical window can pharmacologically produce the same enzyme
    deficiency the mutation produces genetically. It is modelled as its own node because
    it is the mechanistic claim that unifies CDPX1 with warfarin embryopathy and, more
    speculatively, with the vitamin-K-deficiency phenocopies.
  evidence:
  - reference: PMID:7720070
    reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Expression of this gene in COS cells resulted in a heat-labile arylsulfatase
      activity that is inhibited by warfarin.
    explanation: >-
      Demonstrates the warfarin sensitivity of the enzyme in a heterologous expression
      system.
  downstream:
  - target: ARSL Arylsulfatase Deficiency
    description: >-
      Pharmacological inhibition reaches the same molecular endpoint as the genetic
      lesion. The authors advance this as the mechanism of warfarin embryopathy, in
      which a fetus with an intact ARSL gene nonetheless has deficient enzyme activity.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:7720070
      reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        These data indicate that CDPX is caused by an inherited deficiency of a novel
        sulfatase and suggest that warfarin embryopathy might involve drug-induced
        inhibition of the same enzyme.
      explanation: >-
        States the proposed convergence of the genetic and the drug-induced routes on one
        enzyme. The authors' own hedge ("might involve") is preserved here.
- name: Abnormal Cartilage Calcification and Endochondral Ossification
  biological_scale: TISSUE
  description: >-
    Punctate calcification appears in epiphyseal and other cartilage, with a
    distribution that in this disorder is weighted towards the nasal cartilage and the
    distal phalanges rather than towards the proximal long bones. That regional
    weighting is what separates the brachytelephalangic pattern from the rhizomelic one
    radiographically, and it is unexplained.
  cell_types:
  - preferred_term: chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  - preferred_term: growth plate cartilage chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  biological_processes:
  - preferred_term: bone mineralization
    modifier: ABNORMAL
    term:
      id: GO:0030282
      label: bone mineralization
  - preferred_term: endochondral ossification
    modifier: ABNORMAL
    term:
      id: GO:0001958
      label: endochondral ossification
  evidence:
  - reference: PMID:26526591
    reference_title: "Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      X-linked recessive type chondrodysplasia punctata (CDPX1) is a congenital disorder
      of cartilage and bone development with typical findings of stippled epyphises,
      nasomaxillary hypoplasia and short distal phalanges in a male patient.
    explanation: States the cartilage-and-bone-development lesion and its three typical findings.
  downstream:
  - target: Epiphyseal Stippling
    causal_link_type: DIRECT
    description: Punctate calcification of epiphyseal cartilage is the defining radiographic finding.
  - target: Nasomaxillary Hypoplasia
    causal_link_type: DIRECT
    description: >-
      Underdevelopment of the nasal cartilage and maxilla, the craniofacial expression of
      the same cartilage lesion.
  - target: Brachytelephalangy
    causal_link_type: DIRECT
    description: Shortening of the distal phalanges.
  - target: Cervical Spine Stenosis and Instability
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Disordered ossification of the cervical vertebrae and their ligamentous attachments.
    description: >-
      The cervical spine is the site where the dysplasia has its most dangerous
      consequence, and unlike the other skeletal findings it does not improve with age.
- name: Nasomaxillary Hypoplasia
  biological_scale: TISSUE
  description: >-
    Severe underdevelopment of the nasal cartilage with maxillary hypoplasia, producing
    the flat midface and depressed nasal bridge that are the clinical signature of the
    brachytelephalangic pattern. In the newborn it is also a mechanical airway problem.
  evidence:
  - reference: PMID:7720070
    reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      X-linked recessive chondrodysplasia punctata (CDPX) is a congenital defect of bone
      and cartilage development characterized by aberrant bone mineralization, severe
      underdevelopment of nasal cartilage, and distal phalangeal hypoplasia.
    explanation: Names severe underdevelopment of nasal cartilage as a defining feature.
  downstream:
  - target: Hypoplasia of the Maxilla
    causal_link_type: DIRECT
    description: The maxillary component of the midface hypoplasia.
  - target: Depressed Nasal Bridge
    causal_link_type: DIRECT
    description: >-
      The flat nasal bridge is the surface expression of the underdeveloped nasal cartilage
      named in this node.
  - target: Respiratory Distress
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Nasal airway narrowing in an obligate nasal breather.
    description: >-
      Nasal-airway compromise in infancy, the reason nasal stents and supplemental oxygen
      appear in the management recommendations.
phenotypes:
- name: Epiphyseal Stippling
  category: Skeletal
  description: >-
    Punctate epiphyseal calcification, present in infancy and resolving with skeletal
    maturation.
  phenotype_term:
    preferred_term: Epiphyseal stippling
    term:
      id: HP:0010655
      label: Epiphyseal stippling
    temporality: TRANSIENT
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      X-linked chondrodysplasia punctata 1 (CDPX1) is characterized by chondrodysplasia
      punctata (stippled epiphyses), brachytelephalangy (shortening of the distal
      phalanges), and nasomaxillary hypoplasia.
    explanation: Names stippled epiphyses as one of the three characterizing findings.
- name: Brachytelephalangy
  category: Skeletal
  description: Shortening of the distal phalanges of the fingers, giving the disorder its descriptive name.
  phenotype_term:
    preferred_term: Shortening of all distal phalanges of the fingers
    term:
      id: HP:0006118
      label: Shortening of all distal phalanges of the fingers
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "brachytelephalangy (shortening of the distal phalanges)"
    explanation: Defines brachytelephalangy as distal phalangeal shortening.
- name: Hypoplasia of the Maxilla
  category: Craniofacial
  description: >-
    Maxillary hypoplasia, part of the nasomaxillary underdevelopment; may progress to
    retrognathia requiring reconstruction.
  phenotype_term:
    preferred_term: Hypoplasia of the maxilla
    term:
      id: HP:0000327
      label: Hypoplasia of the maxilla
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Severe maxillary hypoplasia or maxillary retrognathia may require reconstructive
      surgery in older individuals.
    explanation: Documents maxillary hypoplasia as a manifestation with surgical consequences.
- name: Depressed Nasal Bridge
  category: Craniofacial
  description: >-
    Flat nasal bridge and midface, following underdevelopment of the nasal cartilage.
  phenotype_term:
    preferred_term: Depressed nasal bridge
    term:
      id: HP:0005280
      label: Depressed nasal bridge
  evidence:
  - reference: PMID:7720070
    reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "severe underdevelopment of nasal cartilage"
    explanation: >-
      Underdevelopment of the nasal cartilage is the anatomic basis of the depressed
      nasal bridge.
- name: Cervical Spine Stenosis and Instability
  category: Skeletal
  description: >-
    Narrowing and instability of the cervical canal - the one CDPX1 finding that does not
    improve with growth and that carries a risk of cord injury. It drives interval
    flexion-extension imaging, activity restriction, and pre-anaesthetic assessment.
  phenotype_term:
    preferred_term: Cervical spine instability
    term:
      id: HP:0010646
      label: Cervical spine instability
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Assess for cervical spine instability by flexion-extension radiographs every six to
      twelve months until growth is completed.
    explanation: >-
      The recommended interval imaging establishes cervical instability as an expected and
      actively monitored complication.
- name: Respiratory Distress
  category: Respiratory
  description: >-
    Respiratory involvement in infancy, largely from nasal-airway compromise, sometimes
    requiring nasal stents and oxygen.
  phenotype_term:
    preferred_term: Respiratory distress
    term:
      id: HP:0002098
      label: Respiratory distress
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment of respiratory difficulty as per ENT and/or pulmonologist including nasal
      stents and oxygen as needed.
    explanation: Documents respiratory difficulty and its airway-directed management.
- name: Mixed Hearing Impairment
  category: Otologic
  description: >-
    Mixed conductive and sensorineural hearing loss, common enough that it can be the
    presenting complaint - in one reported case hearing loss brought the patient to
    genetics before any skeletal diagnosis was suspected.
  phenotype_term:
    preferred_term: Mixed hearing impairment
    term:
      id: HP:0000410
      label: Mixed hearing impairment
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "mixed conductive and sensorineural hearing loss, and intellectual disability"
    explanation: Names mixed conductive and sensorineural hearing loss among the significant problems.
  - reference: PMID:26526591
    reference_title: "Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report on a male patient refered to clinical geneticist for congenital hearing
      loss and mild dysplastic signs, both phenotypic features being relatively unspecific
      and non suggestive of CDPX1 in first instance.
    explanation: >-
      Documents a case in which hearing loss, not the skeletal dysplasia, was the
      presenting feature.
- name: Intellectual Disability
  category: Neurologic
  description: >-
    Intellectual disability occurs in a minority; most affected males have minimal
    morbidity, and developmental support is recommended only for those affected.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although most affected males have minimal morbidity and skeletal findings that
      improve by adulthood, some have significant medical problems including respiratory
      involvement, cervical spine stenosis and instability, mixed conductive and
      sensorineural hearing loss, and intellectual disability.
    explanation: >-
      Support is recorded as partial because the source places intellectual disability
      explicitly in the minority "some have" group rather than among the characterizing
      features.
genetic:
- name: ARSL
  relationship_type: CAUSATIVE
  presence: Present
  gene_term:
    preferred_term: ARSL
    term:
      id: hgnc:719
      label: ARSL
  notes: >-
    ARSL (arylsulfatase L; previous symbols ARSE, CDPX, CDPX1) at Xp22.33. Roughly
    60-75% of molecularly solved cases are found by sequencing and a further ~25% by
    deletion/rearrangement analysis, so a normal sequencing result does not exclude the
    diagnosis. The important negative is that most patients meeting clinical criteria
    have no ARSL variant at all - those belong to the phenocopy group rather than to
    this gene.
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of CDPX1 is established in a male proband with typical clinical and
      radiographic findings and a hemizygous ARSL pathogenic variant identified by
      molecular genetic testing.
    explanation: States the gene and the hemizygous requirement for diagnosis.
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified mutations in seven individuals."
    explanation: >-
      Seven of eleven patients meeting clinical criteria had identifiable variants in
      this systematic series.
inheritance:
- name: X-linked recessive inheritance
  inheritance_term:
    preferred_term: X-linked recessive inheritance
    term:
      id: HP:0001419
      label: X-linked recessive inheritance
  description: >-
    Affected individuals are hemizygous males. Female carriers have not so far been
    reported as affected - the contrast with CDPX2, where the heterozygous female is the
    typical patient, follows from CDPX1 being recessive rather than dominant at the
    X-linked locus.
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males who inherit the pathogenic variant will be affected; females who inherit the
      pathogenic variant will be carriers and thus far have not been affected.
    explanation: States the X-linked recessive pattern and the carrier status of females.
diagnosis:
- name: Molecular testing of ARSL
  description: >-
    Diagnosis requires typical clinical and radiographic findings plus a hemizygous ARSL
    variant. There is no biochemical confirmatory test: enzyme assay is not clinically
    available, and because the substrate is unknown there is no metabolite to measure.
    That is a real diagnostic handicap in a disorder whose most important differentials
    are acquired.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Testing of ARSL enzymatic activity is not currently available on a clinical basis."
    explanation: States that no clinical enzyme assay exists.
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "molecular analysis remains the only confirmatory diagnostic test"
    explanation: Confirms that molecular testing is the sole confirmatory route.
- name: Maternal history as part of the diagnostic workup
  description: >-
    Because the phenocopies are indistinguishable on examination, evaluating a stippled
    male infant means taking a maternal history - coumarin exposure, vitamin K status,
    autoimmune disease - as seriously as the molecular test. The largest systematic
    series found maternal conditions in three of the four patients who had no ARSL
    variant.
  diagnosis_term:
    preferred_term: diagnostic procedure
    term:
      id: NCIT:C18020
      label: Diagnostic Procedure
  evidence:
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of the remainder, three had maternal conditions that further expand the phenocopy
      group.
    explanation: >-
      Documents that maternal conditions accounted for most of the variant-negative
      patients in this series.
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We extracted clinical information from all prior reports over the past decade and
      show that there are few distinguishing features on examination between these two
      groups of patients.
    explanation: >-
      Establishes that examination alone cannot separate genetic CDPX1 from its
      phenocopies, which is why the maternal history carries diagnostic weight.
treatments:
- name: Cervical spine surveillance, immobilization, and decompression
  description: >-
    Flexion-extension radiographs every six to twelve months until growth is complete;
    a cervical collar or spinal fusion for instability; decompression for stenosis. Neck
    extension, neck flexion, and contact sports are to be avoided in an affected
    individual with instability, and the cervical spine should be imaged before general
    anaesthesia.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: cervical spine instability
    term:
      id: HP:0010646
      label: Cervical spine instability
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Instability of the cervical spine may require a cervical collar or spinal fusion.
      Decompression for cervical spine stenosis as needed.
    explanation: States the interventions for cervical instability and stenosis.
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In case of general anesthesia, the cervical spine should be assessed by imaging
      prior to the procedure.
    explanation: >-
      Documents the pre-anaesthetic imaging requirement, an actionable safety consequence
      of the diagnosis.
- name: Airway management in infancy
  description: Nasal stents and supplemental oxygen for respiratory difficulty from nasal hypoplasia.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: respiratory distress
    term:
      id: HP:0002098
      label: Respiratory distress
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment of respiratory difficulty as per ENT and/or pulmonologist including nasal
      stents and oxygen as needed.
    explanation: States the airway interventions.
- name: Hearing aids and pressure equalization tubes
  description: Standard management of the mixed conductive and sensorineural hearing loss.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: therapeutic procedure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  target_phenotypes:
  - preferred_term: mixed hearing impairment
    term:
      id: HP:0000410
      label: Mixed hearing impairment
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hearing aids and pressure equalization tubes may be needed for hearing loss."
    explanation: States the hearing-loss interventions.
- name: Maxillofacial reconstruction
  description: Reconstructive surgery for severe maxillary hypoplasia or retrognathia in older individuals.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: orthopedic surgical procedure
    term:
      id: NCIT:C16186
      label: Orthopedic Surgical Procedure
  target_phenotypes:
  - preferred_term: hypoplasia of the maxilla
    term:
      id: HP:0000327
      label: Hypoplasia of the maxilla
  evidence:
  - reference: PMID:20301713
    reference_title: "Chondrodysplasia Punctata 1, X-Linked."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Severe maxillary hypoplasia or maxillary retrognathia may require reconstructive
      surgery in older individuals.
    explanation: States the reconstructive indication.
differential_diagnoses:
- name: Warfarin (coumarin) embryopathy
  description: >-
    The phenocopy that the gene-discovery work itself explained. A fetus exposed to a
    coumarin derivative in early gestation develops a virtually identical picture,
    proposed to be drug-induced inhibition of the same warfarin-sensitive arylsulfatase.
    It is a differential diagnosis rather than a form of CDPX1, since the ARSL gene is
    intact.
  distinguishing_features:
  - A maternal history of coumarin exposure in the first trimester
  - No ARSL variant is identifiable
  - Female infants can be affected, whereas genetic CDPX1 affects hemizygous males
  evidence:
  - reference: PMID:7720070
    reference_title: "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A virtually identical phenotype is observed in the warfarin embryopathy, which is
      due to the teratogenic effects of coumarin derivatives during pregnancy.
    explanation: >-
      States that the phenotypes are virtually identical, which is why this is the primary
      differential rather than a distant one.
- name: Vitamin K deficiency and maternal autoimmune phenocopies of brachytelephalangic CDP
  description: >-
    Early-gestation vitamin K deficiency and maternal autoimmune disease, notably
    systemic lupus erythematosus, produce the same brachytelephalangic picture. In the
    largest systematic series these accounted for most of the variant-negative patients,
    and the authors report few distinguishing features on examination. One report of a
    newborn with brachytelephalangic CDP, maternal SLE, and two unrelated de novo variants
    goes further and argues the radiographic pattern is not a diagnostic entity at all.
  distinguishing_features:
  - A maternal history of autoimmune disease or of a condition causing vitamin K deficiency
  - No ARSL variant is identifiable
  - Affected infants of either sex
  evidence:
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The major clinical features in these patients are also present in a group now
      recognized as phenocopies, due to vitamin K deficiency in early gestation or
      maternal autoimmune disease.
    explanation: Names the two acquired phenocopy mechanisms.
  - reference: PMID:32506814
    reference_title: "Maternal SLE and brachytelephalangic chondrodysplasia punctata in a patient with unrelated de novo RAF1 and SIX2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This case shows that BCDP is most probably not a diagnostic entity and can be
      associated with various conditions associated with CDP including maternal SLE.
    explanation: >-
      The strongest published statement of the position that the brachytelephalangic
      pattern names a convergence rather than a disease.
- name: X-linked chondrodysplasia punctata 2 (Conradi-Hunermann-Happle syndrome)
  disease_term:
    preferred_term: X-linked chondrodysplasia punctata 2
    term:
      id: MONDO:0020603
      label: X-linked chondrodysplasia punctata 2
  description: >-
    The other X-linked CDP and the source of most naming confusion, since both are
    "X-linked chondrodysplasia punctata". They share almost nothing else: CDPX2 is
    dominant, sterol-pathway, male-lethal, and mosaic.
  distinguishing_features:
  - CDPX2 affects heterozygous females and is lethal in hemizygous males; CDPX1 affects hemizygous males and spares carrier females
  - CDPX2 has ichthyosis, follicular atrophoderma, scarring alopecia, and cataract; CDPX1 has none of these
  - CDPX2 has asymmetric rhizomelic shortening; CDPX1 has brachytelephalangy and nasomaxillary hypoplasia
  - CDPX2 has a diagnostic sterol profile; CDPX1 has no biochemical marker at all
discussions:
- discussion_id: arsl_substrate_unknown
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Unidentified Sulfated Substrate Accumulates or Fails to Be Processed
  - pathophysiology#ARSL Arylsulfatase Deficiency
  prompt: >-
    What is the physiological substrate of ARSL, and what sulfated species links its
    loss to abnormal cartilage mineralization?
  rationale: >-
    The gene has been known since 1995 and the enzyme deficiency has been demonstrated
    directly in patients, yet neither the substrate nor the function of the enzyme has
    been identified. Every consequence follows from that: there is no biochemical
    diagnostic test, no metabolite to monitor, no target for therapy, and a pathophysiology
    node in this entry that can only be named negatively. The gap is unusual among the
    chondrodysplasia punctata group, where the peroxisomal and sterol-pathway members all
    have solved biochemistry and quantitative diagnostic assays. Two clues constrain the
    answer - the enzyme's warfarin sensitivity, and the fact that early-gestation vitamin
    K deficiency phenocopies the disorder - which together point towards a
    vitamin-K-dependent process, but no candidate substrate has been confirmed.
  proposed_experiments:
  - experiment_id: arsl_substrate_identification
    name: Substrate identification for ARSL
    description: >-
      Untargeted sulfatomic profiling of ARSL-deficient versus control chondrocytes or
      cartilage, with the warfarin-inhibited enzyme as a pharmacological comparator, to
      identify sulfated species that accumulate on loss of activity; candidates then tested
      as direct substrates of recombinant enzyme.
  evidence:
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Neither the substrate nor function of the encoded warfarin-sensitive arylsulfatase
      has been identified and molecular analysis remains the only confirmatory diagnostic
      test.
    explanation: States the gap and its immediate diagnostic consequence.
- discussion_id: bcdp_entity_status
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - disease#X-linked Chondrodysplasia Punctata 1
  - differential_diagnoses#Vitamin K deficiency and maternal autoimmune phenocopies of brachytelephalangic CDP
  prompt: >-
    Is "brachytelephalangic chondrodysplasia punctata" a disease, or a radiographic
    convergence point reached by an inherited sulfatase deficiency and by several
    unrelated maternal-fetal insults?
  rationale: >-
    This is a nosological question with practical teeth. The ISDS nosology lists the
    ARSL-related entity as a single row, and this dismech entry follows it - but the
    clinical literature reports that most patients meeting the clinical criteria have no
    ARSL variant, that examination cannot separate the genetic from the acquired cases, and
    in one report that the pattern "is most probably not a diagnostic entity". If that view
    is right, the useful dismech object might eventually be a grouping over the convergent
    causes rather than a disease entry per cause. dismech keeps the gene-defined entry
    because that is what the nosology lists and what MONDO:0010555 denotes, and records the
    acquired routes as differentials rather than as subtypes, but the boundary is not
    settled.
  evidence:
  - reference: PMID:32506814
    reference_title: "Maternal SLE and brachytelephalangic chondrodysplasia punctata in a patient with unrelated de novo RAF1 and SIX2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This case shows that BCDP is most probably not a diagnostic entity and can be
      associated with various conditions associated with CDP including maternal SLE.
    explanation: States the position that the radiographic pattern is not a disease entity.
  - reference: PMID:18348268
    reference_title: "Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This study supports heterogeneity for CDPX1-like phenotypes and sorting these out
      will help to define the biological pathway and genetic contributors.
    explanation: >-
      The authors of the largest systematic series frame the heterogeneity of the clinical
      category as unresolved.
notes: >-
  Curated as its own dismech entry because the ISDS 2023 nosology lists it as its own row
  (NOS 23-0010) with its own gene and inheritance, and because it is mechanistically the
  most distant member of its group - the only one whose biochemical lesion is unsolved and
  the only one with a well-documented set of acquired phenocopies. The warfarin-embryopathy
  and maternal-autoimmune/vitamin-K phenocopies are deliberately kept as differential
  diagnoses rather than modelled as subtypes or as environmental entries on this file: they
  are not ARSL disorders, and folding them in would assert an identity that the literature
  is actively disputing. A member of the Chondrodysplasia_Punctata grouping.

📚

References & Deep Research

References

5

PMID:20301713

Chondrodysplasia Punctata 1, X-Linked.

No top-level findings curated for this source.

PMID:7720070

A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy.

No top-level findings curated for this source.

PMID:18348268

Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata.

No top-level findings curated for this source.

PMID:26526591

Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss.

No top-level findings curated for this source.

PMID:32506814

Maternal SLE and brachytelephalangic chondrodysplasia punctata in a patient with unrelated de novo RAF1 and SIX2 variants.

No top-level findings curated for this source.

X-linked Chondrodysplasia Punctata 1

Ask OpenScientist

OpenScientist Report

Classifications

Mappings

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Source YAML

References & Deep Research

References